Israel Hayom is a media organization founded on the belief that the Israeli public deserves better journalism—more balanced, more accurate, and more reliable. Journalism that speaks rather than shouts. Journalism that is trustworthy, objective, and matter-of-fact. A different kind of journalism, offered free of charge. The first print edition was published on July 30, 2007, and in 2010 Israel Hayom became the Israeli newspaper with the highest weekday readership. The newspaper’s publisher is Dr. Miriam Adelson. Its Editor-in-Chief is Omar Lachmanovitch, and its founding editor is Amos Regev. Israel Hayom’s Hebrew and English websites, as well as its Android and iOS applications, provide around-the-clock news coverage, exclusive content, breaking news and updates, analysis and commentary, video, podcasts, and live broadcasts. The digital platforms of Israel Hayom include news and opinion channels covering culture and entertainment, lifestyle, technology, sports, business and consumer affairs, health, military affairs, food, Judaism, tourism, and automobiles. In 2021, a new Hebrew-language website and mobile application were launched to provide users with a fast, up-to-date, secure, and convenient experience. The content of the newspaper’s print edition is also available online through a daily digital edition and can be received via newsletter. “The Israel Hayom Clique,” the publication’s exclusive benefits club, offers website users discounts and special promotions on products and services. Israel Hayom welcomes feedback, criticism, and suggestions for improvement from its readers. You can contact the organization by email at hayom@israelhayom.co.il

Sunday Oct 11, 2026
NEWSLETTER
www.israelhayom.com
  • Home
  • News
    • Israel
    • Israel at War
    • Middle East
    • United States
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
  • In Memoriam
www.israelhayom.com
  • Home
  • News
    • Israel
    • Israel at War
    • Middle East
    • United States
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
  • In Memoriam
www.israelhayom.com
Home Health & Wellness

Tel Aviv-based startup uses artificial intelligence to help patients find best treatments

StuffThatWorks co-founder Yael Elish, former head of product at Waze: "People are the ones that hold in-depth knowledge about themselves, their condition, and the way treatments affect them."

by  ILH Staff
Published on  07-24-2020 07:36
Last modified: 07-24-2020 08:23
Israel will try to purchase promising COVID vaccineDavid Cohen / JINI

When the number of users of a community reaches several hundred, StuffThatWorks' proprietary machine learning kicks in, and treatments can be ranked by level of effectiveness | Illustration: David Cohen / JINI

Share on FacebookShare on Twitter

An Israeli community platform that uses artificial intelligence and crowdsourcing to help patients discover what medical treatments work best and for whom has raised $9 million in seed funding.

The Tel Aviv-based StuffThatWorks empowers patients with chronic medical conditions to share their experiences and broaden the base of "data" they use to determine what course of treatment to pursue. The more contributors the smarter and more personalized the insights get. The data formed becomes available to everyone and is updated in real-time, along the process.

Follow Israel Hayom on Facebook and Twitter

StuffThatWorks' approach applies to common conditions such as diabetes and ADHD, but also rare and even orphan diseases that receive little attention and for which little information is available. There are already 110 "condition communities" open.

Once 100 users start contributing to a certain community, it will become possible to share and browse initial insights about the condition including age of onset, symptoms, aggravating factors, and treatments.

When the number of users of a community reaches several hundred, StuffThatWorks' proprietary machine learning kicks in, and treatments can be ranked by level of effectiveness.

With thousands of people contributing, the system will be able to predict the most effective treatments for both subgroups and individuals.

The more people participate and contribute to the data quality and the community, the more points they accrue, and the greater their influence on what will be researched next.

"People are the ones that hold in-depth knowledge about themselves, their condition, and the way treatments affect them," explains CEO and co-founder of StuffThatWorks Yael Elish, former Head of Product for Waze.

"Collecting this knowledge in an organized and structured way across is the only way to compare effectiveness in scale. And when that's done across all chronic conditions it creates a gold mine of data that can dramatically advance and facilitate research to the benefit of both the patient and the medical community," Elish says.  

Arnon Dinur, a partner at 83North, one of the seed investors, said that "Few companies manage to implement crowdsourcing in a way that significantly impacts the world – and applying it to such an important domain, in an elegant way that scales across so many conditions, has never been done."

StuffThatWorks was founded by Elish, CTO Ron Held, and Chief Data Scientist Yossi Synett.

Subscribe to Israel Hayom's daily newsletter and never miss our top stories!

Tags: ADHDartificial intelligenceIsraelWaze

Related Posts

Nobel Prize in medicine goes to 3 for unlocking light-activated brain cellsJonathan Nackstrand / AFP

Nobel Prize in medicine goes to 3 for unlocking light-activated brain cells

by Erez Linn

The groundbreaking research allows scientists to manipulate individual nerve cells using light, opening new avenues in neuroscience.

Israeli company on verge of breakthrough in celiac drug developmentGetty Images/iStockphoto

Israeli company on verge of breakthrough in celiac drug development

by Nitzan Cohen

TEV '408 succeeded in blocking intestinal damage from gluten exposure, positioning Teva for a potentially lucrative entry into a market...

Nearly half of young Israeli men would preserve sperm, study findsIDF Spokesperson's Unit

Nearly half of young Israeli men would preserve sperm, study finds

by Maytal Yasur Beit-Or

Prof. Bella Savitsky, who lost her son on October 7, is now pushing for a state funded sperm bank for...

Menu

Analysis 

Archaeology

Blogpost

Business & Finance

Culture

Exclusive

Explainer

Environment

 

Features

Health

In Brief

Jewish World

Judea and Samaria

Lifestyle

Cyber & Internet

Sports

 

Diplomacy 

Iran & The Gulf

Gaza Strip

Politics

Shopping

Terms of use

Privacy Policy

Submissions

Contact Us

About Us

The first issue of Israel Hayom appeared on July 30, 2007. Israel Hayom was founded on the belief that the Israeli public deserves better, more balanced and more accurate journalism. Journalism that speaks, not shouts. Journalism of a different kind. And free of charge.

All rights reserved to Israel Hayom

Hosted by sPD.co.il

  • Home
  • News
    • Israel at War
    • Israel
    • United States
    • Middle East
    • Sports
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
    • Environment & Wildlife
    • Health & Wellness
  • In Memoriam
  • Subscribe to Newsletter
  • Submit your opinion
  • Terms and conditions

All rights reserved to Israel Hayom

Hosted by sPD.co.il

Newsletter

[contact-form-7 id=”508379″ html_id=”isrh_form_Newsletter_en” title=”newsletter_subscribe”]

  • Home
  • News
    • Israel at War
    • Israel
    • United States
    • Middle East
    • Sports
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
    • Environment & Wildlife
    • Health & Wellness
  • In Memoriam
  • Subscribe to Newsletter
  • Submit your opinion
  • Terms and conditions

All rights reserved to Israel Hayom

Hosted by sPD.co.il